Skip to content
TrueHub offers expert tech insights, product reviews, and i…

Zimbabwe Turns Down ‘Lopsided’ US Healthcare Assistance Package Due to Information Concerns

Medical funding illustration
The proposed US financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has turned down a major American health deal valued at 367 million US dollars (£272m) spanning five years due to the United States' request for sensitive data.

The decision was revealed following a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".

An official spokesman has since explained that the United States was requesting biological samples for scientific study and commercial gain but was unwilling to guarantee the resulting advantages from any future treatments.

"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Background

Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were raised about the security of Kenyans' health data.

Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to boost openness and accountability.

According to statements, Sixteen African countries have to date signed similar agreements, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," the Ambassador commented.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Our nation was requested to surrender its biological resources and data over an extended period, with no equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.

"Effectively, our nation would provide the raw materials for medical research with no certainty that the final treatments would be accessible to our citizens if a new health crisis emerge."

Sovereignty and Global Health

He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting frameworks already established via the international organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.

"This framework is designed to guarantee that when a nation contributes its data, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," he added.

"We are open to further discussions with our American counterparts on how future co-operation might be arranged in a way that honours the independence and dignity of each country."

Medical Community Response

A leading public health body said it acknowledged the government's concerns, but suggested that talks should continue given that much of the country's HIV programmes relied on external financing.

"Where specific concerns arise, including those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.

This impasse underscores the continuing tensions between accepting vital foreign assistance and protecting local interests in an increasingly data-driven world.

About the author

Sara Miller

Elara Vance is a tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society.

TrueHub

Type to search articles.